Lsv Asset Management Amphastar Pharmaceuticals, Inc. Transaction History
Lsv Asset Management
- $46.7 Billion
- Q3 2024
A detailed history of Lsv Asset Management transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Lsv Asset Management holds 80,400 shares of AMPH stock, worth $3.61 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
80,400
Previous 80,400
-0.0%
Holding current value
$3.61 Million
Previous $3.22 Million
21.33%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding AMPH
# of Institutions
287Shares Held
35.1MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$267 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$122 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$95.9 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$87.5 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$72.5 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.2B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...